BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Indian Country ECHO - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://indiancountryecho.npaihb.org
X-WR-CALDESC:Events for Indian Country ECHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261027T120000
DTEND;TZID=America/Los_Angeles:20261027T130000
DTSTAMP:20260830T224255Z
CREATED:20260830T224255Z
LAST-MODIFIED:20260830T224255Z
UID:43995-1793102400-1793106000@indiancountryecho.npaihb.org
SUMMARY:GLP-1 Therapies and the Syndemic in Indian Country: Clinical Outcomes\, Emerging Applications\, and Access | October 27\, 2026
URL:https://indiancountryecho.npaihb.org/event/glp-1-therapies-october-27-2026/
ORGANIZER;CN="Northwest Portland Area Indian Health Board":MAILTO:echo@npaihb.org
DESCRIPTION:Join: https://echo.zoom.us/j/99475693462?pwd=NGlaMjBrNHZkclBOSXRySHNHMzB4Zz09\n\nSignup: https://indiancountryecho.npaihb.org/join-us/\n\nWe invite you to join Indian Country ECHO for a General Session on GLP-1 Therapies and the Syndemic in Indian Country: Clinical Outcomes\, Emerging Applications\, and Access. In this presentation\, Dr. Hannah Wenger\, and Dr. Nicholas Duca\, compare the burden of obesity and related metabolic disease among American Indian and Alaska Native populations with the broader US population\, explain the pharmacology and patient-centered outcomes of GLP-1 receptor agonists and dual GIP/GLP-1 agonists\, describe the relevance of incretin-based therapies to substance use disorders and syndemic care and review medication access across public and private insurances as well as IHS and other federal health entities. CE will be available. \nTo join\, simply click here at the time of the General Session (October 27th at 12pm PT): https://echo.zoom.us/j/99475693462?pwd=NGlaMjBrNHZkclBOSXRySHNHMzB4Zz09 \n  \nSpeaker(s): Hannah Wenger\, MD | Associate Physician\, Division of General Internal Medicine\, Massachusetts General Hospital; Instructor in Medicine\, Harvard Medical School; Partner\, The Raven Collective; Nicholas S. Duca\, MD | Associate Professor of Medicine\, Penn State College of Medicine; General Internist\, Penn State Health Milton S. Hershey Medical Center
END:VEVENT
END:VCALENDAR